Caricamento...
CAR T-cell Therapy for Pancreatic Cancer
Chimeric antigen receptor (CAR) T-cell therapy utilizes genetic engineering to redirect a patient’s own T cells to target cancer cells. The remarkable results in hematological malignancies prompted investigating this approach in solid tumors such as pancreatic cancer. The complex tumor microenvironm...
Salvato in:
| Pubblicato in: | J Surg Oncol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5491361/ https://ncbi.nlm.nih.gov/pubmed/28346697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jso.24627 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|